591 related articles for article (PubMed ID: 16794801)
21. Cholangiocarcinoma Resembling IgG4-related Sclerosing Cholangitis.
Akahoshi K; Kanno A; Miwata T; Nagai H; Yokoyama K; Ikeda E; Ando K; Tamada K; Fukushima N; Lefor AK; Yamamoto H
Intern Med; 2023 Dec; 62(23):3495-3500. PubMed ID: 37081688
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis and management of cholangiocarcinoma in primary sclerosing cholangitis.
Ahrendt SA; Pitt HA; Nakeeb A; Klein AS; Lillemoe KD; Kalloo AN; Cameron JL
J Gastrointest Surg; 1999; 3(4):357-67; discussion 367-8. PubMed ID: 10482687
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence.
Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
Am J Surg Pathol; 2007 Jun; 31(6):907-13. PubMed ID: 17527079
[TBL] [Abstract][Full Text] [Related]
24. A case of follicular cholangitis mimicking hilar cholangiocarcinoma.
Fujii M; Shiode J; Niguma T; Ito M; Ishiyama S; Fujiwara A; Nose S; Yoshioka M; Mimura T
Clin J Gastroenterol; 2014 Feb; 7(1):62-7. PubMed ID: 26183511
[TBL] [Abstract][Full Text] [Related]
25. Cystic dilatation of intrahepatic bile ducts in primary sclerosing cholangitis.
Genève J; Dubuc N; Mathieu D; Zafrani ES; Dhumeaux D; Métreau JM
J Hepatol; 1990 Sep; 11(2):196-9. PubMed ID: 2254629
[TBL] [Abstract][Full Text] [Related]
26. AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma.
Bowlus CL; Arrivé L; Bergquist A; Deneau M; Forman L; Ilyas SI; Lunsford KE; Martinez M; Sapisochin G; Shroff R; Tabibian JH; Assis DN
Hepatology; 2023 Feb; 77(2):659-702. PubMed ID: 36083140
[No Abstract] [Full Text] [Related]
27. IgG4-related sclerosing cholangitis: the cholangiocarcinoma mimic.
Sivakumaran Y; Le Page PA; Becerril-Martinez G; Beasley WD; Anderson LA; Joseph DM; Falk GL
ANZ J Surg; 2014 Jun; 84(6):486-7. PubMed ID: 24164754
[No Abstract] [Full Text] [Related]
28. Hepatic hilar inflammatory pseudotumor mimicking cholangiocarcinoma with cholangitis and phlebitis--a variant of primary sclerosing cholangitis?
Nonomura A; Minato H; Shimizu K; Kadoya M; Matsui O
Pathol Res Pract; 1997; 193(7):519-25; discussion 526. PubMed ID: 9342759
[TBL] [Abstract][Full Text] [Related]
29. Endoscopic therapy in primary sclerosing cholangitis: outcome of treatment and risk of cancer.
Linder S; Söderlund C
Hepatogastroenterology; 2001; 48(38):387-92. PubMed ID: 11379315
[TBL] [Abstract][Full Text] [Related]
30. Isolated IgG4-related sclerosing cholangitis misdiagnosed as malignancy in an area with endemic cholangiocarcinoma: a case report.
Rungsakulkij N; Sornmayura P; Tannaphai P
BMC Surg; 2017 Feb; 17(1):17. PubMed ID: 28202062
[TBL] [Abstract][Full Text] [Related]
31. Case of IgG4-related sclerosing cholangitis with a normal serum IgG4 level: report of a case.
Mizutani S; Suzuki H; Yoshida H; Arima Y; Kitayama Y; Uchida E
J Nippon Med Sch; 2012; 79(5):367-72. PubMed ID: 23123394
[TBL] [Abstract][Full Text] [Related]
32. Primary sclerosing cholangitis and cholangiocarcinoma: pathogenesis and modes of diagnostics.
Ehlken H; Schramm C
Dig Dis; 2013; 31(1):118-25. PubMed ID: 23797133
[TBL] [Abstract][Full Text] [Related]
33. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.
Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228
[TBL] [Abstract][Full Text] [Related]
34. Superficial thrombophlebitis, dysplasia, and cholangiocarcinoma in primary sclerosing cholangitis.
Martins EB; Fleming KA; Garrido MC; Hine KR; Chapman RW
Gastroenterology; 1994 Aug; 107(2):537-42. PubMed ID: 8039630
[TBL] [Abstract][Full Text] [Related]
35. An animal model of benign bile-duct stricture, sclerosing cholangitis and cholangiocarcinoma and the role of epidermal growth factor receptor in ductal proliferation.
Cheifetz RE; Davis NL; Owen DA
Can J Surg; 1996 Jun; 39(3):193-7. PubMed ID: 8640617
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis.
Boberg KM; Jebsen P; Clausen OP; Foss A; Aabakken L; Schrumpf E
J Hepatol; 2006 Oct; 45(4):568-74. PubMed ID: 16879890
[TBL] [Abstract][Full Text] [Related]
37. Urine proteomic analysis differentiates cholangiocarcinoma from primary sclerosing cholangitis and other benign biliary disorders.
Metzger J; Negm AA; Plentz RR; Weismüller TJ; Wedemeyer J; Karlsen TH; Dakna M; Mullen W; Mischak H; Manns MP; Lankisch TO
Gut; 2013 Jan; 62(1):122-30. PubMed ID: 22580416
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic criteria for IgG4-related sclerosing cholangitis based on cholangiographic classification.
Nakazawa T; Naitoh I; Hayashi K; Okumura F; Miyabe K; Yoshida M; Yamashita H; Ohara H; Joh T
J Gastroenterol; 2012 Jan; 47(1):79-87. PubMed ID: 21947649
[TBL] [Abstract][Full Text] [Related]
39. Primary sclerosing cholangitis in which differential diagnosis from gallbladder carcinoma was difficult.
Kobayashi H; Hosotani R; Imai Y; Wada K; Kajiwara T
J Hepatobiliary Pancreat Surg; 2005; 12(2):151-4. PubMed ID: 15868081
[TBL] [Abstract][Full Text] [Related]
40. [Clinicopathological features of non-specific cholangitis mimicking cholangiocarcinoma].
Takayashiki T; Furukawa K; Ohtsuka M
Nihon Shokakibyo Gakkai Zasshi; 2020; 117(8):689-694. PubMed ID: 32779586
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
